www.nordion.com

NORDIONCorporate Presentation

June 2, 2014

2

Caution on Forward Looking Statements

This presentation contains forward-looking statements, within the meaning of applicable securities laws, including under

applicable Canadian securities laws and the “safe harbor” provisions of the United States Private Securities Litigation Reform Act

of 1995. These statements can be identified by expressions of belief, expectation or intention, as well as those statements that are

not historical fact. The words “may”, “will”, “could”, “should”, “would”, “outlook”, “believe”, “plan”, “anticipate”, “estimate”, “expect”

and similar words and expressions are also intended to identify forward-looking statements. Forward-looking statements are

necessarily based on estimates and assumptions made by us in light of our experience and our perception of historical trends,

current conditions and expected future developments, as well as other factors that we believe are appropriate in the

circumstances, but which are inherently subject to significant business, political, economic and competitive uncertainties and

contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-

looking statements. Accordingly, this presentation is subject to the disclaimer and qualified by the assumptions, qualifications and

risk factors referred to in our 2013 Annual Information Form (AIF) and our 2014 Management Information Circular, as amended.

We caution readers not to place undue reliance on the Company’s forward-looking statements, as a number of factors could

cause our actual results, performance or achievements to differ materially from any forward-looking statements. We do not

assume any obligation to update or revise any forward-looking statements, whether written or oral, that may be made from time to

time by us or on our behalf, except as required by applicable law.

3

About Nordion

Delivering quality products to our global

customers for more than 60 years, our product

portfolio includes:

• Sterilization Technologies

• Medical Isotopes

Nordion is a health science company that

provides market-leading products used for

the prevention, diagnosis and treatment of

disease.

4

A Global Company

APPROXIMATELY

400 EMPLOYEESSUPPLY OVER

500 CUSTOMERSAROUND

30 PRODUCTSACROSS MORE THAN

40 COUNTRIES

64%UNITED STATES

23%ROW

8%EUROPE

5%CANADA

F2013 REVENUES BY REGION - $232.8M*

*Revenues and regional breakdown include Targeted Therapies business, which was divested in July 2013 to BTG plc.

5

108.7 95.4 96.1

122.8

101.0 100.3

42.6

48.5 36.3

0

50

100

150

200

250

300

2011 2012 2013

2011- 2013 Financial HighlightsRevenue Trend (US$ Millions)

* In July 2013, Nordion divested its Targeted Therapies business to BTG plc

Medical Isotopes Targeted Therapies*Sterilization Technologies

6

46.139.0 35.3

38.3

29.425.9

12.7

14.1

3.0

0

20

40

60

80

100

120

2011 2012 2013

2011- 2013 Financial HighlightsSegment Earnings Trend (US$ Millions)

Medical Isotopes Targeted Therapies*Sterilization Technologies

Excludes corporate segment

* In July 2013, Nordion divested its Targeted Therapies business to BTG plc

7

Q2 2014 Results

20.2

33.8

22.7

40.9

13.2

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

80.0

2013 2014

Targeted TherapiesSterilization Technologies Medical Isotopes

Segmented Revenue (US$ millions)

Segmented Earnings* (US$ millions)

* Excludes corporate segment

6.4

15.45.2

16.0

1.1

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

2013 2014Q2 Q2

8

Q2 2014

Nordion sponsors and

participates in The Royal’s

Inspiration Awards Gala to

support those affected by

mental illness

February April

March April

Sterigenics enters into a

definitive agreement to

acquire Nordion

Nordion delays its Annual

Meeting to accommodate

recent transaction

announcement

Nordion provides an updated

financial outlook for 2014

Q2 2014 Timeline

9

Leading Products in Global Markets

POTENTIAL >

PRIORITY >

STERILIZATION

TECHNOLOGIES

ADVANTAGE >

Optimize Medical Isotopes business

• Secure long-term supply

• Maintain customer relationships

Maintain Sterilization business;

selectively invest in growth:

• Geographic expansion

• New applications

• Global leader in cobalt-60

• Significant barriers to entry

• Solid cash flow and gross margins

• Recurring revenue base

• A global provider in processing,

packaging, & delivery

• Extensive regulatory expertise and

logistics & distribution network

Approximately 40% of single-use medical

products worldwide are sterilized using

gamma sterilization technologies

Over 10,000 hospitals worldwide use

radioisotopes in medical procedures with

about 90% being for diagnosis.

MEDICAL

ISOTOPES

10

Specialty Isotopes: Sterilization Technologies

• Gamma sterilization is focused on

the prevention of disease

• Co-60 is used to sterilize medical devices,

instruments and supplies and food

• Customers of Co-60 include

contract sterilization service providers

and medical device and product manufacturers

• The Nordion Gamma Centre of Excellence is a

world class applied research and specialty gamma

processing facility to promote and expand the use

of gamma globally

• Nordion manufactures Co-60 irradiation sources,

and designs, constructs and maintains commercial

gamma sterilization systems

11

MARKET MIX PRODUCTS DRIVERS

80%

10%

• Stents

• Patches

• Tissue

• Regen medicine

+ Aging population

+ Enhance devices

+ Leverage drugs

+ Stem cell research

10%

Sterilization Market Segmentation

MEDICAL & SURGICAL

BIO-ACTIVE DEVICES

FOOD SAFETY

• Syringes

• Catheters

• Drapes, gowns

• Sutures, gloves

+ Aging population

+ Min invasive surgery

+ Smaller devices

+ Material

• Fruits & vegetables

• Spices

• Meat and poultry

• Ready To Eat (RTE)

+ FDA labeling

+ USDA FEA

+ Food safety concerns

10%

80%

12

Specialty Isotopes: Medical Isotopes

• Medical isotopes are used to prevent, diagnose

and treat disease

• Main isotope supply sources

are nuclear reactors and cyclotrons

• Primary product is Mo-99, which decays for use in

Technetium-99 (Tc-99m) generators, used in

imaging to diagnose heart disease and cancers

• Other Key Reactor Isotopes:

– Xenon-133 (Xe-133), used in lung scans;

– Iodine-131 (I-131), used to treat hyperthyroidism, thyroid cancer and

non-Hodgkin’s lymphoma;

– Iodine-125 (I-125), used to treat prostate cancer;

– Yttrium-90 (Y-90), used to treat liver cancer.

• Key Cyclotron Isotopes:

– Iodine-123 (I-123), used to diagnose thyroid disease;

– Strontium-82 (Sr-82), used to manufacture rubidium-82 generators,

which are used in imaging to diagnose heart disease

– Thallium-201 (Tl-201), used to diagnose and assess risk of coronary

artery heart disease;

– Palladium-103 (Pd-103), used to treat prostate cancer;

– Indium-111 (In-111) and Gallium-67 (Ga-67) (both used to diagnose

infection and cancer) at our Vancouver facilities

13

Medical Isotopes (Mo-99) Supply Chain

• Established, reliable facilities providing high-quality isotopes to global customers

• Specialty skills in operations, regulatory affairs and global logistics

Irradiation of

HEU targets to

produce crude

isotopes

NUCLEAR

REACTORS

Purification of

Mo-99 and

distribution to global

radiopharmaceutical

manufacturers

MEDICAL ISOTOPE

PROCESSORS

Tc-99m

Generator

manufacturing

and distribution to

radiopharmacies

RADIOPHARMACEUTICAL

MANUFACTURERS

Unit dose

compounding and

distribution to

hospital/departments

RADIOPHARMACIES

AND HOSPITALS

Critical physiological

diagnosis enabling

informed therapeutic

decisions

PHYSICIANS

AND PATIENTS

14

Nordion Environmental, Health,

and Safety (EH&S) Program

• Creating a workplace that enriches

the health and well-being of Nordion

employees

• Demonstrating Environmental, Health,

and Safety (EH&S) regulatory excellence

• Improving EH&S performance –

continually

• Managing EH&S with excellence

Recipient of Canada’s Safest

Employers - Gold level award

October, 2013

15

Nordion Environmental, Health,

and Safety (EH&S) Program

• Implementing measures in the design and operation of all of

our facilities to keep radiation dose received by workers and

the public ALARA (as low as reasonably achievable)

• Implementing an ISO 14001-based environmental

management (EMS) system at our Ottawa site

• Establishing EH&S objectives and targets annually

to continually improve our performance

• Maintaining - and building on - a comprehensive training

program for employees and contractors

• Engraining EH&S excellence into the Nordion culture

• Investing in a world class approach to EH&S

ISO 14001: 2004 certified

Recipient of the Government of Canada 2007 ENERGY STAR ® Market Transformation Award

Practitioner of LeanSigma, a methodology used to continually improve processes

Recipient of an unprecedented ten-year license renewal from the Canadian Nuclear Safety Commission (CNSC)

16

In the Community

Other Programs:

• Employee Giving Program - Nordion

makes donations to not-for-profit

organizations nominated by employees

• Proud sponsor of:

• The Gala for Research, to support

the Ottawa Hospital Research Institute,

the research arm of The Ottawa Hospital

• The Royal’s Inspiration Awards Gala to

support those affected by mental illness

• The CHEO Healing Garden to promote health

and well-being for patients, their families and

the staff who care for them.

• The Advancing Care for All Ages program at

the Queensway Carleton Hospital

Ride the RideauSponsor of Ride the Rideau since its inauguration in 2010, Nordion has helped to raise

over $6.4 million for cancer research at The Ottawa Hospital Research Institute.

17

The talented, dedicated and

resilient people that make

up Nordion share a single

purpose:

• Maintain a global leadership

position in our key markets

• Build value for shareholders

through the execution of our

strategic priorities

• Be a trusted, world-class provider

of healthcare products to our

customers

Business Outlook

www.nordion.com

Find out more at

www.nordion.com

Follow us at

http://twitter.com/NordionInc